Krystal Biotech, Inc.
KRYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,479 | $3,369 | $2,019 | $1,553 |
| - Cash | $345 | $358 | $162 | $341 |
| + Debt | $7 | $8 | $9 | $8 |
| Enterprise Value | $4,142 | $3,019 | $1,866 | $1,219 |
| Revenue | $291 | $51 | $0 | $0 |
| % Growth | 473% | – | – | – |
| Gross Profit | $270 | $48 | $0 | $0 |
| % Margin | 93.1% | 93.9% | – | – |
| EBITDA | $110 | -$91 | -$117 | -$66 |
| % Margin | 37.8% | -180.1% | – | – |
| Net Income | $89 | $11 | -$140 | -$70 |
| % Margin | 30.7% | 21.6% | – | – |
| EPS Diluted | 3 | 0.39 | -5.49 | -3.13 |
| % Growth | 669.2% | 107.1% | -75.4% | – |
| Operating Cash Flow | $123 | -$89 | -$101 | -$48 |
| Capital Expenditures | -$4 | -$12 | -$53 | -$68 |
| Free Cash Flow | $119 | -$101 | -$154 | -$116 |